More Rhythm Pharmaceuticals, Inc. news Rhythm Pharmaceuticals, Inc.NASDAQ: RYTM Rhythm Pharmaceuticals Announces Updates on MC4R Pathway Programs at R&D Event Dec 6, 2023 · Issued by Rhythm Pharmaceuticals, Inc. As issuedPlain English Watch Rhythm Pharmaceuticals explain it↗Rhythm Pharmaceuticals, Inc. (RYTM) Q2 2026 Earnings Call · Replay · Aug 4-- Phase 3 trial evaluating setmelanotide in pediatric patients ages 2-
